Find verified Bremelanotide acetate (PT-141) API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Bremelanotide acetate (PT-141) for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Bremelanotide acetate (PT-141) API.
Alternate Names: Vyleesi, PT141 acetate, PT-141
CAS No: 1607799-13-2
PubChem CID: 91971505
Mol Formula: C52H72N14O12
Mol Weight: 1085.2 g/mol
IUPAC Name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-y -Show More
Therapeutic use: Compounding Pharmacy Peptides, Sexual dysfunction agents
Drug Class: Compounded peptides, Peptides
Commercial / Development Status: Commercial APIs
Source / Manufacturing Origin: Peptide APIs
API Description: PT-141 is the development code for bremelanotide, a synthetic cyclic heptapeptide that works as a melanocortin receptor agonist. The FDA-approved product is Vyleesi, which treats hypoactive sexual desire disorder (HSDD) in premenopausal women.
